Patent · US Active

Injectable nanoparticulate olanzapine formulations

US7910577B2 · kind B2 · utility

21Cited by

68References

17Claims

0Family size

Assignee

Elan Pharma International Ltd. · IE

Inventors

Gary Liversidge · West Chester, US
Scott Jenkins · San Francisco, US
Elaine Liversidge · West Chester, US

Key dates

Filing date	Nov 16, 2005
Grant date	Mar 22, 2011
Priority date	—
Expiry date	Jan 26, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/915
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are injectable formulations of nanoparticulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise nanoparticulate olanzapine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.